Viking Therapeutics

VKTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.512 B

$30.11 +3.86%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$359.6M

Loss-making

Shares outstanding

116,652,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#70Organon & Co.OGN$3.59B
#71Enliven TherapeuticsELVN$3.58B
#72Viking TherapeuticsVKTX$3.51B
#73Arcus BiosciencesRCUS$3.30B
#74Arcutis BiotherapeuticsARQT$3.26B

What if Viking Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$259,522.43

Per share 8,619× higher

Bitcoin $1.72T

$14,742.91

Per share 490× higher

Nvidia $5.48T

$46,975.74

Per share 1,560× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Viking Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.